Arda Ural, EY Partner
What is the outlook for the medtech sector in 2017?
In this video, Parthenon-EY Managing Director and Co-head of Health Care Dan Shoenholz and EY Partner Arda Ural discuss the main theme for the year: how companies in the sector can attain growth.
Dan shares four ways medtech companies need to look at growth throughout the year:
- Scale in the therapeutic category
- Breadth with the larger hospital purchasing customers
- Designing products for value
- Services that differentiate
He also shares insight on how “the internet of things” is changing the medtech sector in terms of improved communication and availability of home-based care.
Arda highlights medtech companies’ use of venture funds as well as portfolio optimization and the outlook for divestments.